Your browser doesn't support javascript.
loading
Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model.
Ando, Shiori; Funato, Michinori; Ohuchi, Kazuki; Kameyama, Tsubasa; Inagaki, Satoshi; Seki, Junko; Kawase, Chizuru; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Kaneko, Hideo; Hara, Hideaki.
Afiliação
  • Ando S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Funato M; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan. Electronic address: mfunato@me.com.
  • Ohuchi K; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Kameyama T; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Inagaki S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Seki J; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Kawase C; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Tsuruma K; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Shimazawa M; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
  • Kaneko H; Department of Clinical Research, National Hospital Organization, Nagara Medical Center, Gifu, Japan.
  • Hara H; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu, Japan.
Eur J Pharmacol ; 814: 161-168, 2017 Nov 05.
Article em En | MEDLINE | ID: mdl-28826912
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atrofia Muscular Espinal / Antipirina / Células-Tronco Pluripotentes Induzidas Limite: Animals / Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atrofia Muscular Espinal / Antipirina / Células-Tronco Pluripotentes Induzidas Limite: Animals / Humans Idioma: En Revista: Eur J Pharmacol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão